MilliporeSigma Webinars

  1. Which Ingredient Are You Missing In Your Gene Therapy Success Recipe? 3/25/2021

    In this podcast, Ratish Krishnan, Associate Director for Cell & Gene Therapy talks about the tremendous promise gene therapies have for changing the healthcare paradigm and solutions to some of the biggest challenges in gene therapy manufacturing.

  2. Developing A Scalable Upstream Bioreactor Process For Lentiviral Vector Production In Suspension 3/8/2021

    Gene therapies hold the promise to change lives. As your path to patients accelerates, how can you assure the robust process design, intensification and scalability that meets your evolving manufacturing needs? And what benefits can a templated process bring to your commercial success? Learn the answers to these questions and more in this webinar.

  3. How Biosafety Assurance Can Be Both Rapid And Purposeful 2/24/2021

    A discussion on how novel treatment modalities such as viral vectors and the urgent need for SARS-CoV-2 treatments and vaccines are driving the advance of biopharma. 

  4. Effect Of Product Concentration On Continuous Parvovirus Retentive Filtration 2/23/2021

    This video illustrates how careful process development and system design can address higher-concentration intermediate challenges and optimize virus filtration processes.

  5. Biosafety In Gene Therapy: Applying The Latest Regulatory Guidance For RCL Testing 2/23/2021

    The use of lentivirus vectors to produce groundbreaking gene therapies is on the rise. Ensuring the biosafety and quality of these vectors is achieved through a multi-tiered testing approach. For lentivirus-based therapies, generation of replication competent particles is a potential risk. While improvements in design and manufacturing have decreased the probability of producing replication competent viruses, regulatory agencies provide guidelines to test for their presence at multiple stages in production.

  6. Assess Pyrogenic Risk With The Monocyte Activation Test 2/5/2021

    Microbial risk in pharmaceutical processing cannot be limited to viable microorganisms. Learn how the MAT can help you to assess the pyrogenic risk resulting from your production process.

  7. Unlocking The Potential Of mRNA Vaccines And Therapeutics: A Manufacturing Perspective 1/12/2021

    This webinar highlights the potential of mRNA therapies and focuses on the manufacturing process associated challenges, solutions and perspectives from synthesis to delivery.

  8. Re-Imagining Vaccine Manufacturing To Address Global Health Challenges 10/27/2020

    In the last decade, biopharmaceutical industries have mobilized quickly in response to pandemics. Developing vaccines and manufacturing large doses in response to an emergency is often constrained by existing platforms and facility configurations. Learn how vaccine manufacturing can evolve to tackle future global health challenges.

  9. Addressing The Challenge Of Scalability In Viral Vectors 10/18/2020

    Early viral vector process development for cell and gene therapies is critical to assure a production strategy that supports commercial needs. In this webinar, you will learn the importance of planning for scalability and manufacturability from the earliest stages of process development and how a scalable templated process can reduce time needed to move from product development to commercialization. 

  10. Evaluating Viral Clearance For Continuous Processes 10/18/2020

    Is viral clearance a hurdle to implementing continuous processing? Here we share virus spiking alternatives that may pave the way for evaluating viral clearance by chromatography steps.